|
|
Research progress on pyroptosis and its role in atherosclerosis#br# |
XU Lu1 WANG He2 YUE Ke1 WEI Ke1 XIE Jinhong2 GUAN Huaimin2 |
1.The First Clinical Medical College, Henan University of Chinese Medicine, Henan Province, Zhengzhou 450000, China;
2.Ward Three, Department of Cardiovascular Medicine, the First Affiliated Hospital of Henan University of Chinese Medicine, Henan Province, Zhengzhou 450000, China |
|
|
Abstract Pyroptosis is a new type of programmed cell death, which is significantly different in form from traditional cell death such as apoptosis and necrosis. Atherosclerotic cardiovascular disease seriously affects the physical and mental health of residents. Recent studies have found that vascular endothelial cells, macrophages and smooth muscle cells all experience pyroptosis, which affects the development process of atherosclerosis. This article intends to review the relationship between pyroptosis and atherosclerosis, in order to provide new ideas and find new directions for the treatment of cardiovascular diseases.
|
|
|
|
|
[1] 赵冬.新中国成立70年来我国人群血脂流行病学研究回顾与进展[J].中国医药,2019,14(10):1441-1444.
[2] Cookson BT,Brennan MA. Pro-inflammatory programmed cell death [J]. Trends Microbiol,2001,9(3):113-114.
[3] 刘超,高嘉良,王阶.冠心病细胞焦亡的分子机制及其新药靶点的研究进展[J].医学综述,2021,27(2):246-252.
[4] 张梁,李婧.细胞焦亡与PCSK 9在动脉粥样硬化中的研究进展[J].中国医药导报,2020,17(21):54-57.
[5] Bai B,Yang Y,Ji S,et al. MicroRNA-302c-3p inhibits endothelial cell pyroptosis via directly targeting NOD-,LRR- and pyrin domain-containing protein 3 in atherosclerosis [J]. J Cell Mol Med,2021,25(9):4373-4386.
[6] Lin Y,Liu M,Chen E,et al. Bone marrow-derived mesenchymal stem cells microvesicles stabilize atherosclerotic plaques by inhibiting NLRP3-mediated macrophage pyroptosis [J]. Cell Biol Int,2021,45(4):820-830.
[7] Chen X,He WT,Hu L,et al. Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis [J]. Cell Res,2016,26(9):1007-1020.
[8] Gong W,Shi Y,Ren J. Research progresses of molecular mechanism of pyroptosis and its related diseases [J]. Immunobiology,2020,225(2):151884.
[9] Ding J,Wang K,Liu W,et al. Pore-forming activity and structural autoinhibition of the gasdermin family [J]. Nature,2016,535(7610):111-116.
[10] Liang H,Liu Y. Gasdermins pore cell membrane to pyroptosis [J]. Sci China Life Sci,2016,59(10):1090-1092.
[11] Shi J,Zhao Y,Wang Y,et al. Inflammatory caspases are innate immune receptors for intracellular LPS [J]. Nature,2014,514(7521):187-192.
[12] Liu Q,Zhang D,Hu D,et al. The role of mitochondria in NLRP3 inflammasome activation [J]. Mol Immunol,2018, 103:115-124.
[13] Rajam?覿ki K,Lappalainen J,O?觟rni K,et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages:a novel link between cholesterol metabolism and inflammation [J]. PLoS One,2010,5(7):e11765.
[14] Gong T,Yang Y,Jin T,et al. Orchestration of NLRP3 inflammasome activation by ion fluxes [J]. Trends Immunol,2018,39(5):393-406.
[15] Afrasyab A,Qu P,Zhao Y,et al. Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients [J]. Heart Vessels,2016, 31(8):1218-1229.
[16] Murgia A,Erta M,Suri JS,et al. CT imaging features of carotid artery plaque vulnerability [J]. Ann Transl Med,2020,8(19):1261.
[17] Roumenina LT,Rayes J,Frimat M,et al. Endothelial cells:source,barrier,and target of defensive mediators [J]. Immunol Rev,2016,274(1):307-329.
[18] Bar A,Targosz-Korecka M,Suraj J,et al. Degradation of glycocalyx and multiple manifestations of endothelial dysfunction coincide in the early phase of endothelial dysfunction before atherosclerotic plaque development in apolipoprotein E/low-density lipoprotein receptor-deficient mice [J]. J Am Heart Assoc,2019,8(6):e011171.
[19] Xing SS,Yang J,Li WJ,et al. Salidroside decreases ath-erosclerosis plaque formation via inhibiting endothelial cell pyroptosis [J]. Inflammation,2020,43(2):433-440.
[20] Yao F,Jin Z,Lv X,et al. Hydroxytyrosol acetate inhibits vascular endothelial cell pyroptosis via the HDAC11 signaling pathway in atherosclerosis [J]. Front Pharmacol,2021,12:656272.
[21] Hu Q,Zhang T,Yi L,et al. Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells [J]. Biofactors,2018,44(2):123-136.
[22] Wu X,Zhang H,Qi W,et al. Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis [J]. Cell Death Dis,2018,9(2):171.
[23] Lopez-Pastrana J,Ferrer LM,Li YF,et al. Inhibition of Caspase-1 activation in endothelial cells improves angiogenesis:a novel therapeutic potential for ischemia [J]. J Biol Chem,2015,290(28):17485-17494.
[24] Duewell P,Kono H,Rayner KJ,et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals [J]. Nature,2010,464(7293):1357-1361.
[25] Shi X,Xie WL,Kong WW,et al. Expression of the NLRP3 inflammasome in carotid atherosclerosis [J]. J Stroke Cerebrovasc Dis,2015,24(11):2455-2466.
[26] Xu YJ,Zheng L,Hu YW,et al. Pyroptosis and its relationship to atherosclerosis [J]. Clin Chim Acta,2018, 476:28-37.
[27] Zheng F,Xing S,Gong Z,et al. Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipo-protein E-deficient mice [J]. Mediators Inflamm,2014, 2014:507208.
[28] Peng X,Chen H,Li Y,et al. Effects of NIX-mediated mitophagy on ox-LDL-induced macrophage pyroptosis in atherosclerosis [J]. Cell Biol Int,2020,44(7):1481-1490.
[29] Ding W,Li J,Wang L,et al. ClC-2 inhibition prevents macrophage foam cell formation by suppressing Nlrp3 inflammasome activation [J]. Biosci Biotechnol Biochem,2020,84(10):2096-2103.
[30] Jiang M,Sun X,Liu S,et al. Caspase-11-gasdermin D-mediated pyroptosis is involved in the pathogenesis of atherosclerosis [J]. Front Pharmacol,2021,12:657486.
[31] Lin J,Zhou S,Zhao T,et al. TRPM7 channel regulates ox-LDL-induced proliferation and migration of vascular smooth muscle cells via MEK-ERK pathways [J]. FEBS Lett,2016,590(4):520-532.
[32] Pan H,Reilly MP. A protective smooth muscle cell transition in atherosclerosis [J]. Nat Med,2019,25(8):1194-1195.
[33] Pan J,Han L,Guo J,et al. AIM2 accelerates the atherosclerotic plaque progressions in ApoE-/- mice [J]. Biochem Biophys Res Commun,2018,498(3):487-494.
[34] Li Y,Niu X,Xu H,et al. VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis [J]. Exp Cell Res,2020,389(1):111847.
[35] Liu J,Wang Y,Liao Y,et al. Circular RNA PPP1CC promotes Porphyromonas gingivalis-lipopolysaccharide-induced pyroptosis of vascular smooth muscle cells by activating the HMGB1/TLR9/AIM2 pathway [J]. J Int Med Res,2021,49(3):1-13. |
|
|
|